
The right medical device marketing agency depends entirely on which problem you are buying help with. Most founders are choosing between execution shops when the thing blocking them is a market that has not been engineered yet.
So this list sorts 14 agencies into four categories by the job they do, and gives you the diagnostic to run before you take a single call.
Every published ranking I checked scores agencies on inputs that have nothing to do with your problem. First Page Sage weights its list at 30% notable clients, 30% average reviews, 25% leadership experience, 10% year founded and 5% headquarters location.
Only two of the 14 firms here work upstream on category and market engineering. The other 12 are execution partners, and they are excellent at execution.
Four agencies work on medical devices exclusively. Podymos has 17 people across London and Boston and works only with device companies. The Matchstick Group says it has launched more than 50 medical device brands across the US, LATAM and EMEA.
Five are life sciences generalists where devices are one sector among pharma, biotech and diagnostics. That is a strength if you need scale and a weakness if your buyer is a hospital value analysis committee.
The diagnostic takes an afternoon. If you cannot name the category you are competing in, no agency on this list can fix that for you with campaigns.
Published agency rankings score firms on inputs, not on fit. The most transparent example is First Page Sage, which publishes its exact weighting: notable clients 30%, average reviews 30%, leadership experience 25%, year founded 10%, headquarters location 5%.
Those are all real signals. None of them tell you whether that agency can solve the specific problem stopping your device.
It's worth reading First Page Sage's methodology because it's honest about what it measures.
The firm ranks itself first on its own list. That's standard in this genre, and I'm doing it here too. The difference is what the ranking is for.
A weighting like that answers "which agency is most established?"
But you're not shopping for the most established agency. You're shopping for the one whose core competence maps onto what's stopping your revenue.
Podymos gets closer. Its US agency roundup lists firms alphabetically and says outright that the right choice depends on your needs, your size, and your stage.
That's the correct frame. It's why this list is sorted rather than ranked.
Because here is what happens when the frame is wrong. A founder with FDA clearance, clinical data and no adoption hires a performance marketing agency. The agency does good work.
Twelve months later the funnel is full of the wrong people and the board wants to know why. The agency did not fail. It was hired to solve a problem the company did not have.
I wrote a companion piece on the three questions that vet a medical device marketing agency which handles the interview itself. This piece handles the step before it.
A marketing problem means buyers understand the category, know they need something like your device, and are choosing between options.
A market problem means the category does not exist in your buyer's head yet, so there is nothing for your marketing to compete inside. Campaigns amplify demand. They cannot manufacture a category.
The fastest way to tell them apart is to ask what happens in the room.
When a surgeon or a value analysis committee hears your pitch, do they argue about whether you're better than an alternative? Or do they struggle to place what you are?
The first is a marketing problem. The second is a market problem, and no amount of paid media closes it.
FDA clearance is the starting line, not the finish line. Clinical validation isn't commercial traction, and the gap between the two is where most medtech companies stall.
Bruce Cleveland named this the traction gap. I broke down how it applies to medtech specifically in an earlier post.
Three signals tell you the problem is upstream. Your win rate against "do nothing" is worse than your win rate against named competitors.
Your champions love the device but cannot get it through procurement. And your investors keep saying they want more traction without telling you what would count as traction.
If two of those three are true, hiring an execution agency now converts runway into activity. Run the Traction Gap Diagnostic first. It takes minutes and it tells you which half of this list to read.
Two firms on this list work upstream, before campaigns exist. They build the market narrative, define the category, and establish market-product fit rather than assuming it. This is the smallest category in the industry and the one most founders skip.
MarketCraft. My firm. We do market engineering for medtech companies that need early market signal before they scale.
The work runs through four phases: Craft the Narrative, Prime Early Belief, Amplify the Signal, and Engineer Market Pull. It is built for CEOs at an inflection point, usually a raise, a launch, or a scaling decision.
I'll be direct about the limits, because they're published on our own site.
MarketCraft isn't the right call if you have no validated market problem, if you want content and PR without the strategy underneath, or if leadership can't commit the time and decision authority the work takes.
We also do not publish client names, so if logo proof is what you need to get board approval, start elsewhere on this list.
Sprig Consulting. 18 years in medtech strategic marketing, working coast to coast in the US. The team is drawn from sales, marketing, engineering and reimbursement backgrounds.
The firm reports 250 or more global clients, 100 or more product launches and 40 or more company exits, and names Endotronix, Elucid, Shifamed and Asahi Intecc USA among its clients.
Sprig covers upstream strategy and new product planning, then carries through to execution. MarketCraft doesn't.
So if you want one firm holding both ends, Sprig is the closer fit. If you want the market engineered and your own team executing, we are.
Four agencies here work exclusively or near-exclusively on medical devices. That focus matters because device marketing carries constraints most agencies never meet, including regulatory review of claims, clinician and procurement audiences who buy differently, and sales cycles measured in quarters rather than weeks.
Icovy. Based in Clearfield, Utah, and the top organic result for this search at the time of writing. Icovy positions itself around helping device and medtech companies position, launch and scale in regulated markets.
It names an unusually deep client list, including Teleflex, Surmodics, Spectrum Plastics, Immucor, Esaote Medical, Kaneka Medical and Turner Imaging Systems. Services run from strategy and brand development through SEO, paid media, web, video and analytics.
The Matchstick Group. Says it has launched more than 50 medical device brands across the US, LATAM and EMEA.
Its stated capabilities are the ones that matter for a launch: strategic positioning, competitive mapping, clinician-centric messaging, regulatory-aware creative, and trade show and sales enablement work.
ParkerWhite. Based in Cardiff-by-the-Sea, California, working across the full product lifecycle with both patient and clinician audiences.
Its portfolio names Avanos, Verathon, FUJIFILM Sonosite, Momentis Surgical, SeaSpine, Orthofix, DJO Global, Halyard Health and Zest Dental Solutions. This is the deepest mid-market and established-manufacturer client list in the group.
Podymos. Founded in 2016, 17 employees, offices in London and Boston, working exclusively with device companies from messaging through sales enablement. The transatlantic footprint is the differentiator if you are running a US launch from Europe or the reverse.
If your device is cleared and your category is understood, this is the group to shortlist. A medical device marketing consultant inside one of these firms will already know what a value analysis committee is, which saves you a quarter of education.
Five firms treat devices as one vertical alongside pharma, biotech, diagnostics and manufacturing. The trade is straightforward. You gain depth of resource, process maturity and cross-sector pattern recognition, and you lose some of the device-specific instinct that a device-only shop carries by default.
Altitude Marketing. Emmaus, Pennsylvania, 20 years in B2B, 35 or more staff, working across life sciences, industrial manufacturing and enterprise technology.
The firm reports an average client retention of three years, which it describes as twice the industry norm. It has the strongest organic search presence of any competitor in this set.
Clarity Quest. Covers health tech, biotech and medtech, and now operates as part of Supreme Optimization. Worth knowing the ownership change before you buy, because it changes who staffs your account.
Cobalt Communications. McGaheysville, Virginia, design-led, working across pharma, biotech, devices, CDMOs and specialty chemicals. Named clients include W.L. Gore and Associates, West Pharmaceutical Services and FUJIFILM Wako.
Elevation Marketing. B2B across several industries with a dedicated device practice, and a stated focus on connected and wearable technology, software as a medical device, medical robotics and diagnostics. Named clients include Vocera, JDRF, Zoetis and Blue Cross Blue Shield.
Marzipan. Liverpool, United Kingdom, covering devices alongside biotech, pharma, diagnostics and contract research organisations. Its stated approach is built around the medtech environment specifically, including regulatory constraints, long sales cycles and multi-stakeholder buying.
The pattern across this group is real capability with divided attention. That is the right trade when your device sits inside a broader life sciences portfolio, and the wrong one when your buyer is a hospital committee you need somebody to already understand.
Three firms here go deep on one channel rather than broad across many. You hire them when you know what to say and need it produced at a standard your team can't hit.
They're the wrong first hire. They're often the right second one.
Aha Media Group. Two decades of medical content, focused on translating complex device information for clinicians, surgeons and patients.
The firm reports that more than 80% of its clients return, and publishes a NeuroPace case study claiming a 64% increase in inbound leads. Other named clients include LymphaPress and Auxano Medical.
First Page Sage. Search, including generative and answer engine optimisation, aimed at small to mid-size device companies.
This matters more than it did two years ago, because buyers now ask an AI model which agencies and devices to consider before they ever open a search results page.
If you want to understand what that shift means for your own site, I covered it in our breakdown of healthcare SEO for medtech.
Healthcare Success. Irvine, California, more than 20 years old, strongest on paid acquisition and patient-facing campaigns.
Its leadership experience concentrates in aesthetics, ophthalmology, oncology, orthopedics, urology and hearing care. That specialty list tells you exactly where the firm fits: elective and patient-choice categories, not capital equipment sold to committees.
Start by answering the diagnostic, not the shortlist. Decide whether your constraint is that buyers cannot place your device, or that they can place it and are not choosing it.
That single answer eliminates two of the four categories above and saves you a month of calls with firms that were never going to fit.
Then apply three filters in order.
First, filter on buyer. If you sell to a hospital value analysis committee, the device-only specialists and the strategy firms stay. If you sell to a patient or a private practice, Healthcare Success and the patient-facing capability at ParkerWhite move up.
Second, filter on stage. Pre-revenue and pre-category means the strategy group. Cleared, selling and trying to accelerate means the device specialists. Established with an internal team that needs augmenting means the single-channel group.
Third, filter on proof they can show you for a device like yours. Not a logo wall. A named account in your device class, and somebody who'll get on a call and describe what happened, including what didn't work.
Three firms is the right number for a final round. Two gives you no comparison, and five means nobody gets a real evaluation.
In my experience working with medtech founders, the agency decision is almost never the decision that determines the outcome. The decision that determines the outcome is whether the company understood its own problem before it went shopping.
I have watched this play out repeatedly. A founder comes out of a clearance with real clinical data and a genuine belief that the hard part is over. The next hire is an agency, because that is what you do next.
And the agency, being competent, does exactly what it was hired for. Nine months on the pipeline is full of the wrong conversations, the burn rate has not changed, and the board is asking harder questions.
The failure was upstream of the agency. Nobody had engineered the market, so the campaigns pushed into a space where the buyer had no frame to receive them.
Great companies don't wait for markets to form. They engineer them, and then execution has something to amplify.
So my advice is unglamorous. Spend an afternoon on the diagnostic before you spend a quarter on a search.
If the answer is a genuine execution problem, this list has 12 firms that will serve you well. Hire one of them quickly.
If it comes back that you have a market problem, hiring any of the 12 first will cost you a year you cannot get back.
Pull-driven demand is built before it is captured. That sequencing is the whole argument, and it is why I sorted this list by job rather than by rank.
Most people enter through one of three doors. Clinical or device sales experience gives you the buyer knowledge that agencies cannot teach, which is how I started at Mazor Robotics.
Agency-side marketing experience in a regulated category transfers well. And regulatory, clinical affairs or reimbursement backgrounds convert into product marketing roles because those functions already understand the claims constraints.
The largest are holding company networks rather than independent firms, including IPG Health, Omnicom Health Group, Publicis Health, Ogilvy Health and Real Chemistry.
They serve pharmaceutical and enterprise healthcare budgets at a scale most device companies do not need. For a device company under roughly $50 million in revenue, a specialist firm will give you more senior attention for less money.
An agency gives you a team and production capacity. A consultant gives you senior judgment without the execution layer. If you have people who can execute and no clarity on what to execute, hire the consultant.
If you have clarity and no capacity, hire the agency. Buying both at once is how budgets get spent twice on the same problem.
Published pricing is rare in this category, so treat any figure you see without a scope attached as unreliable. What you can control is the shape of the engagement.
Ask for a fixed-scope first phase with a defined deliverable rather than an open retainer, and make the second phase contingent on that deliverable landing.
If you are doing this yourself. Run the Traction Gap Diagnostic before you contact anyone on this list.
It tells you whether your constraint sits upstream in the market or downstream in execution. That answer decides which half of this list is even relevant to you.
If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit.
It is the right starting point when the diagnostic says your category has not been built yet and campaigns would be pushing into empty space.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.